Suppr超能文献

重复心脏导管检查后心血管危险因素和血管闭合装置对股动脉的定量影响。

Quantitative impact of cardiovascular risk factors and vascular closure devices on the femoral artery after repeat cardiac catheterization.

机构信息

Department of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA.

出版信息

Am Heart J. 2010 Jan;159(1):125-30. doi: 10.1016/j.ahj.2009.10.023.

Abstract

BACKGROUND

We evaluated the exact quantitative long-term impact of repeated catheterizations, vascular closure devices, and cardiovascular risk factors on the femoral artery after cardiac catheterization.

METHODS

A total of 2,102 available femoral angiograms from 827 consecutive patients were analyzed using caliper-based quantitative vascular analysis. These patients underwent coronary interventions between January 2005 and April 2007 and had at least one additional catheterization procedure through the ipsilateral femoral access site from December 2001 until January 2008. Multivariate analysis was performed to control for confounding variables. The primary outcome was change in artery size.

RESULTS

The average punctured artery diameter was 6.5 +/- 2.1 mm. The average time between the first case and last follow-up was 349 days. There was no significant change of the punctured artery size over time after the index procedure (P = .15) and no change associated with the use of vascular closure devices (P = .25) after multivariate analysis. Smaller arteries were associated with female gender (-1.22 mm, P < .0001), presence of angiographic peripheral vascular disease (PVD, -1.19 mm, P < .0001), and current (-0.48 mm, P = .001) or former (-0.23 mm, P = .01) smoking status, whereas previous statin therapy was associated with an increase in artery size (+0.47 mm, P < .0001). Vascular closure devices were used less often compared with manual compression in cases preceding the first detection of angiographic PVD (P < .001).

CONCLUSION

Vascular closure devices are not associated with a change in the artery size or progression of PVD. Overall, there is no change in vessel size over time after repeat catheterizations, with a decrease in vessel size associated with current and former smoking and an increase with previous statin therapy.

摘要

背景

我们评估了重复使用导管、血管闭合装置以及心血管危险因素对心脏导管检查后的股动脉的精确长期影响。

方法

对 827 例连续患者的 2102 例可利用的股动脉血管造影进行卡尺定量血管分析。这些患者于 2005 年 1 月至 2007 年 4 月接受了冠状动脉介入治疗,并且自 2001 年 12 月至 2008 年 1 月至少有一次通过同侧股动脉入路进行的额外导管插入术。进行了多变量分析以控制混杂变量。主要结果是动脉大小的变化。

结果

平均穿刺动脉直径为 6.5 +/- 2.1 毫米。首次病例和最后随访之间的平均时间为 349 天。指数操作后,动脉穿刺大小随时间没有明显变化(P =.15),并且在多变量分析后,与血管闭合装置的使用无关(P =.25)。较小的动脉与女性(-1.22 毫米,P <.0001)、存在血管造影外周血管疾病(PVD,-1.19 毫米,P <.0001)以及当前(-0.48 毫米,P =.001)或以前(-0.23 毫米,P =.01)吸烟状态相关,而以前的他汀类药物治疗与动脉大小的增加相关(+0.47 毫米,P <.0001)。在首次检测到血管造影 PVD 之前的病例中,血管闭合装置的使用频率低于手动压迫(P <.001)。

结论

血管闭合装置与动脉大小的变化或 PVD 的进展无关。总体而言,重复使用导管后,血管大小随时间没有变化,血管大小减小与当前和以前的吸烟有关,而以前的他汀类药物治疗则增加。

相似文献

6
Posterior wall capture and resultant common femoral occlusion complicating StarClose access closure.
J Vasc Surg. 2008 Aug;48(2):469-71. doi: 10.1016/j.jvs.2008.03.013.
7
The safety and efficacy of the StarClose Vascular Closure System: the ultrasound substudy of the CLIP study.
Catheter Cardiovasc Interv. 2006 Nov;68(5):684-9. doi: 10.1002/ccd.20898.

引用本文的文献

2
Vascular closure device failure in contemporary practice.
JACC Cardiovasc Interv. 2012 Aug;5(8):837-44. doi: 10.1016/j.jcin.2012.05.005.

本文引用的文献

1
Risk predictors of retroperitoneal hemorrhage following percutaneous coronary intervention.
Am J Cardiol. 2008 Dec 1;102(11):1473-6. doi: 10.1016/j.amjcard.2008.07.039. Epub 2008 Sep 11.
4
Critical lessons from the ENHANCE trial.
JAMA. 2008 Feb 27;299(8):953-5. doi: 10.1001/jama.299.8.953.
7
A cost-minimization analysis of the angio-seal vascular closure device following percutaneous coronary intervention.
Am J Cardiol. 2007 Mar 15;99(6):766-70. doi: 10.1016/j.amjcard.2006.10.032. Epub 2007 Jan 22.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验